Assessing Dopamine Transporter Occupancy in the Patients With Depression Brain With Toludesvenlafaxine Hydrochloride Extended-Release Tablets Using 11C-CFT Positron Emission Tomography (PET)

NCT06026917 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

15

Enrollment

OTHER

Sponsor class

Conditions

Major Depressive Disorder

Interventions

DRUG: Toludesvenlafaxine hydrochloride sustained-release tablets

Sponsor

Shanghai Mental Health Center

Collaborators

[object Object]